Engage with exhibitors showcasing their latest innovations in an interactive Spotlight Theatre. Witness firsthand the advancements that are shaping the future of Refractive Surgery. These Spotlight Sessions will be in the form of an open theatre presentation accessible to all registered participants.
Spotlight Session:
Company: Tarsus Pharmaceuticals Inc.
Date and Time: 6 March, 11:30 – 11:45
Speaker: Cathy Granitto
Title: Accelerating the Eyelid Health Movement
This presentation outlines Tarsus’ aim of becoming a global leader in eye care. It details the commercial performance of XDEMVY® in the U.S., the first FDA-approved therapy for Demodex blepharitis, along with its planned global expansion. The presentation will also provide an overview of Tarsus’ product pipeline, including potential treatments for ocular rosacea and Lyme disease prevention. Tarsus is committed to evidence generation, education, accessibility, and execution. This mission is supported by a leadership team with extensive experience in eye care and biotechnology.